IBC Life Sciences

IBC Life Sciences has been supporting and supplying the life science industry with specialized information through its conferences and publishing products since 1987. During this time, we have developed a proud tradition of quality learning and networking events, and have established industry-leading North American and European events in three primary market sectors: Drug Discovery, Microtechnology, and Biopharmaceutical Production. IBC has experienced substantial growth led by our emergence as the premier information provider to the market.

Contact Details: Suite 400A, P.O. Box 5195 Westborough Massachusetts 01581-5195 United States of America Tel: 508-616-5550 Fax: 508-616-5533 Email: WWW: www.ibcusa.com/

Loading...

Press Releases on IBC Life Sciences:
IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts	4th August, 2008	IBC Life Sciences	WESTBOROUGH, Mass., Aug. 4 /PRNewswire/ -- Today IBC Life Sciences kicks off the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) World Congress in Boston,
VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress	1st August, 2008	VIA Pharmaceuticals, Inc.	SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular
Millennium Advances Oncology Pipeline	28th July, 2008	Millennium	CAMBRIDGE, Mass., July 28 /PRNewswire/ -- Millennium: The Takeda Oncology Company today announced the initiation of a Phase I trial series of MLN4924, the Company's first-in-class, small
Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data	17th July, 2008	Vical Incorporated	SAN DIEGO, July 17 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced a breakthrough with preliminary clinical trial data demonstrating that DNA vaccines can safely
Vical to Present Phase 1 Data for Vaxfectin(R)-Formulated Pandemic Influenza DNA Vaccines	14th July, 2008	Vical Incorporated	SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced the scheduled presentation of preliminary human safety and immunogenicity data from a Phase 1 trial

BioNews Results for IBC Life Sciences:
IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, California	Individual.com:  Nov 5 2009 6:23AM Matching: ibc life sciences
IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, Calif	Freshnews.com:  Nov 4 2009 8:10PM Matching: ibc life sciences
IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, California	NewsBlaze:  Nov 4 2009 7:00PM Matching: ibc life sciences
IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, California	Earthtimes.org:  Nov 4 2009 7:16PM Matching: ibc life sciences
IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 1-5, 2010 in Carlsbad, California	Earthtimes.org:  Nov 4 2009 7:16PM Matching: ibc life sciences
Promote your company here: BioNewsCast - Press Release Distribution	→View more IBC Life Sciences news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 225 times since April 2007, the link to the organisation's website has been followed 54 times

Search for more companies in Westborough

Search for more companies in Massachusetts

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for IBC Life Sciences